SightfileU.S. market data from official filings
Companies › PBM
PSYENCE BIOMEDICAL LTD (PBM)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001985062 · EDGAR filings · Updated 2026-06-22
PSYENCE BIOMEDICAL LTD (PBM) has 2 institutional managers reporting positions valued at $575.0K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional managers
2
Reported 13F value
$575.0K
Data flags
1 active
from SEC filings
Latest updates
- 2026-06-22 — Annual report (20-F) filed
- 2026-06-10 — SCHEDULE 13G/A filed
- 2026-06-05 — Foreign issuer report (6-K) filed
- 2026-06-03 — SCHEDULE 13D filed
- 2026-04-23 — Foreign issuer report (6-K) filed
- 2026-04-20 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PSYENCE BIOMEDICAL LTD has 2 institutional holders.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2024-01-31 (recurring since 2024-01-31) — source filing. The authoritative details are those stated in the filing itself.
Related companies
Revelation Biosciences Inc (REVB) · CALCIMEDICA (CALC) · Astrotech Corporation (ASTC) · SiNtx Technologies Inc (SINT) · HEARTSCIENCES INC (HSCS) · Cardio Diagnostics Holdings Inc (CDIO)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.